FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/06/089287 [Registered on: 23/06/2025] Trial Registered Prospectively
Last Modified On: 31/05/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   study of Mudgadya Ghrita in management of Abnormal Uterine Bleeding 
Scientific Title of Study   Randomized clinical trial of Mudgadya Ghrita in the Management of Asrigdara(Abnormal Uterine Bleeding) 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Mousumi Boro 
Designation  Post graduate trainee 
Affiliation  Govt Ayurvedic College and Hospital 
Address  Govt Ayurvedic College and Hospital Kamrup Assam 781014 India

Kamrup
ASSAM
781014
India 
Phone  7002135810  
Fax    
Email  mou.boro@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Kaushalya Khakhlary 
Designation  Associate Professor Dept. of Prasuti Tantra evum Stree Roga 
Affiliation  Govt. Ayurvedic College and Hospital 
Address  Department of Prasuti Tantra Evum Stree Roga, Govt. Ayurvedic College and Hospital, jalukbari, guwahati Kamrup Assam 781014 India

Kamrup
ASSAM
781014
India 
Phone  8638787369  
Fax    
Email  drkaushalya01@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Kaushalya Khakhlary 
Designation  Associate professor Dept. of Prasuti Tantra Evum Stree Roga 
Affiliation  Govt. Ayurvedic College and Hospital 
Address  Department of Prasuti Tantra Evum STree Roga, Govt. Ayurvedic College and Hospital, jalikbari, guwahati Kamrup Assam 781014

Kamrup
ASSAM
781014
India 
Phone  8638787369  
Fax    
Email  drkaushalya01@gmail.com  
 
Source of Monetary or Material Support  
Govt Ayurvedic College and Hospital Jalukbari Kamrup Assam 781014 
 
Primary Sponsor  
Name  Mousumi Boro 
Address  Govt Ayurvedic College and Hospital Kamrup Assam 781014 India 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Kaushalya khakhlary  Govt Ayurvedic College and Hospital  Prasuti Tantra and Stree Roga department/ground floor division/room no 10
Kamrup
ASSAM 
8638787369

drkaushalya01@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institute Ethics Committee, Govt Ayurvedic College and Hospital, jalukbari, Ghy-14, Assam  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N920||Excessive and frequent menstruation with regular cycle. Ayurveda Condition: ASRUGDARAH/RAKTAPRADARAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator Arm (Non Ayurveda)-Tranexamic acid Dose- 500 mg Route- oral Frequency - TID after food ( during bleeding period) Duration -3 month
2Intervention ArmDrugClassical(1) Medicine Name: Mudgadya ghrita, Reference: Yoga ratnakar,streeroga adhikar, Route: Oral, Dosage Form: Ghrita, Dose: 12(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 3 Months, anupAna/sahapAna: Yes(details: Lukewarm water), Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Female 
Details  Age group from 18 years to 50 years
Having abnormal uterine bleeding considering duration and quantity of bleeding during menstruation  
 
ExclusionCriteria 
Details  Malignant patients
Coagulation disorders
Severe anaemia
Post menopausal bleeding
Patients with major disease like diabetes mellitus, asthma, kidney disease, liver disease
Uterine fibroid  
 
Method of Generating Random Sequence   Adaptive randomization, such as minimization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Decrease in symptoms like
1.srava pramana(amount of bleeding)
2. Srava kaal( duration of bleeding)
3. Rituchakra avadhi(length of menstrual cycle)
4. Angamarda(body ache)
5. Vedana(pain during menstruation) 
1 month 
 
Secondary Outcome  
Outcome  TimePoints 
Marked improvement has noticed in amount, duration of bleeding, length of menstrual cycle, body ache, pain during menstruation   3 months 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   01/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is a comparative study to establish the efficacy of mudgadya ghrita in the management of Asrigdara
 Total number of patients to be studied is 60 where each group contains 30 samples 
30 patients will be given mudgadya ghrita and rest 30 patients will be given tranexamic acid for a total of 3 months
patients will be followed up after every menstrual cycle for 3 months
 
Close